文献速递心脑血管急症重症综合管理与镇静镇痛

成人危重症患者新发心房颤动:范围综述

New-onset atrial fibrillation in adult critically ill patients: a scoping review.
PubMed 文献 · Intensive Care Med · 2019-05-14
一句话结论危重症患者新发心房颤动发生率差异大(1.7%–43.9%),与卒中、住院时间延长和死亡相关,但管理策略缺乏证据。

该范围综述按PRISMA扩展规范检索PubMed、EMBASE和Cochrane Library,纳入99项研究(79项观察性、20项干预性),评估成人危重症患者新发心房颤动的发生率、危险因素、结局和管理策略。新发心房颤动发生率为1.7%–43.9%,人群间差异很大(证据质量极低)。常见危险因素包括高龄、心血管合并症和脓毒症。新发心房颤动与不良结局相关,包括卒中、住院时间延长和死亡(证据质量极低)。管理策略数据有限,任何干预均无明确获益或 harm 的证据(证据质量极低/低)。

要点

  • 成人危重症患者新发心房颤动发生率为1.7%–43.9%,人群间差异很大(证据质量极低)。
  • 常见危险因素包括高龄、心血管合并症和脓毒症。
  • 新发心房颤动与卒中、住院时间延长和死亡相关(证据质量极低)。
  • 管理策略数据有限,任何干预均无明确获益或 harm 的证据(证据质量极低/低)。

适用人群与场景

  • 成人危重症患者。

研究设计与关键结果

  • 研究类型:范围综述,按PRISMA扩展规范进行,检索PubMed、EMBASE和Cochrane Library,纳入99项研究(79项观察性、20项干预性)。
  • 新发心房颤动发生率为1.7%–43.9%,人群间差异很大(证据质量极低)。
  • 常见危险因素包括高龄、心血管合并症和脓毒症。
  • 新发心房颤动与不良结局相关,包括卒中、住院时间延长和死亡(证据质量极低)。
  • 管理策略数据有限,任何干预均无明确获益或 harm 的证据(证据质量极低/低)。

证据类型、等级与局限

  • 证据类型:范围综述,采用GRADE方法评估证据质量。
  • 局限:原文未报告局限性(注:原文结论指出数据非常有限、当前管理策略并非基于证据)。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: New-onset atrial fibrillation (NOAF) is common and associated with increased morbidity and mortality. However, its clinical importance and management in critically ill patients are not well described. The aim of this scoping review is to assess the epidemiology and management strategies of NOAF during critical illness.

METHOD: The review was conducted in accordance with the PRISMA extension for scoping reviews. We searched PubMed, EMBASE and the Cochrane Library for studies assessing the incidence, outcome and management strategies of NOAF in adult critically ill patients. The quality of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.

RESULTS: A total of 99 studies were included, of which 79 were observational and 20 were interventional. The incidence of NOAF varied from 1.7% to 43.9% with considerable inter-population variation (very low quality of evidence). Commonly identified risk factors for NOAF included higher age, cardiovascular comorbidities and sepsis. The occurrence of NOAF was associated with adverse outcomes, including stroke, prolonged length of stay and mortality (very low quality of evidence). We found limited data on the optimal management strategy with no evidence for firm benefit or harm for any intervention (very low/low quality of evidence).

CONCLUSIONS: The definition and incidence of NOAF in critically ill patients varied considerably and many risk factors were identified. NOAF seemed to be associated with adverse outcomes, but data were very limited and current management strategies are not evidence-based.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Wetterslev M, Haase N, Hassager C, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med. 2019. PMID: 31089761. doi:10.1007/s00134-019-05633-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。